| 摘要 |
<p>The treatment of neurodegenerative related pathologies and/or central nervous system trauma by in vivo the stimulation of endogenous or recombinantly expressed nerve growth factor by administration of a therapeutically effective amount of a β-agonist, α1-agonist, and/or α2-antagonist.</p> |
